Slotved, Hans-Christian
Møller, Jens Kjølseth
Khalil, Mohammad Rohi
Nielsen, Stine Yde
Article History
Received: 18 August 2021
Accepted: 25 October 2021
First Online: 1 November 2021
Declarations
:
: All methods in both the carriage and surveillance studies were carried out in accordance with relevant guidelines and regulations.The carriage study was a part of the main study [CitationRef removed] on quality assessment of PCR tests, which was approved by the Danish Data Protection Agency (j.nr. 2012-58-0018), and do not require approval from an ethics committee. All participants in the carriage study were informed about the project and gave verbal consent to participate.Regarding national laboratory surveillance data on isolates from patients with invasive GBS. The data and samples from patients are collected routinely for national surveillance purposes, no ethical approval or informed consent from patients or guardians are required. Statens Serum Institut (SSI) which is under the auspices of the Danish Ministry of Health, have a general approval by the Danish Data Protection Agency (record number 2007-41-0229) (ExternalRef removed, accessed 14-04-2021, ExternalRef removed, accessed 14-04-2021) to publish the data.
: Not Applicable.
: The authors declare no competing interests.